Mania secondary to cotrimoxazole antibiotherapy: a case report and review of literature

被引:0
作者
Jouart, Marine [1 ]
Ramaholimihaso, Tahiana [2 ]
Hadjoudj, Jed [3 ]
Bermejo, Messaline [4 ]
Kaladjian, Arthur [1 ]
机构
[1] Ctr Hosp Univ Reims Sect Psychiat Adulte, Reims, France
[2] Ctr Hosp Haute Marne, Chaumont, France
[3] Ctr Reg Pharmacovigilance Champagne Ardenne, Reims, France
[4] Ctr Hosp Troyes, Troyes, France
关键词
Antibiomania; Mania; Antibacterial agents/adverse effects; Bipolar disorder trimethoprim; Sulfamethoxazole drug combination; Case report;
D O I
10.1186/s13256-024-05004-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAntibiomania is the manifestation of manic symptoms secondary to taking an antibiotic, which is a rare side effect. In these cases, the antibiotics most often incriminated are macrolides and quinolones, but to our knowledge, there are no published cases of antibiomania secondary to cotrimoxazole. Furthermore, we also provide an update of pharmacovigilance data concerning antibiomania through a search of the World Health Organization (WHO) database.Case presentationWe present the case of a 66-year-old Caucasian man with history of a brief psychotic episode 16 years prior. He received levofloxacin for a urinary infection with Klebsiella pneumoniae, with a switch to cotrimoxazole after 5 days of treatment. Shortly after the introduction of cotrimoxazole, the patient presented with a significant flow of speech, which was incoherent. After 2 days of treatment, levofloxacin was restarted, but given the lack of improvement in symptoms, the patient was hospitalized. Levofloxacin was quickly replaced by ceftriaxone for 3 days without improvement, thus a psychiatric examination was requested. This examination identified manic symptoms, and so psychotropic treatment combining 5 mg of haloperidol and 75 mg of loxapine per day was initiated. Subsequently, there was a gradual improvement in symptoms within a week. Moreover, the results of the various investigations that were carried out came back normal, which this led to suspicion of an iatrogenic cause (antibiotherapy).DiscussionWe discuss the latest pharmacovigilance data and several etiopathogenic hypotheses suggested in literature, with growing interest concerning the microbiota-gut-brain axis. It appears important to pay particular attention when taking antibiotics in the context of bipolar disorder because this association seems to precipitate the appearance of secondary mania. Management consists of stopping the responsible antibiotic, with the possibility of adding psychotropic treatment.ConclusionIt is important to be aware of antibiomania to adopt appropriate and early treatment. We think that this case report could be useful as a clinical reminder and could possibly spark lines of research.
引用
收藏
页数:7
相关论文
共 20 条
[1]   Antinticrobial-induced mania (antibiomania): A review of spontaneous reports [J].
Abouesh, A ;
Stone, C ;
Hobbs, WR .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (01) :71-81
[2]  
ANSM (Agence Nationale de Securite du Medicament et des produits de sante), 2023, Resume des caracteristiques du produit-BACTRIM FORTE, comprime-Base de donnees publique des medicaments Internet
[3]   Using MedDRA - Implications for risk management [J].
Brown, EG .
DRUG SAFETY, 2004, 27 (08) :591-602
[4]  
Crocq MA, 2015, DSM-5: manuel diagnostique et statistique des troubles mentaux, V5, P1176
[5]   Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function [J].
Cussotto, Sofia ;
Strain, Conall R. ;
Fouhy, Fiona ;
Strain, Ronan G. ;
Peterson, Veronica L. ;
Clarke, Gerard ;
Stanton, Catherine ;
Dinan, Timothy G. ;
Cryan, John F. .
PSYCHOPHARMACOLOGY, 2019, 236 (05) :1671-1685
[6]   Case-non case studies: Principles, methods, bias and interpretation [J].
Faillie, Jean-Luc .
THERAPIE, 2018, 73 (03) :247-255
[7]   Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy [J].
Gondalia, Shakuntla ;
Parkinson, Lisa ;
Stough, Con ;
Scholey, Andrew .
PSYCHOPHARMACOLOGY, 2019, 236 (05) :1433-1443
[8]  
Guyader ML., 2019, Revue Francophone des Laboratoires, V2019, P55, DOI [10.1016/S1773-035X(19)30329-6, DOI 10.1016/S1773-035X(19)30329-6]
[9]  
HAS (Haute Autorite de Sante), 2023, Patient avec un trouble bipolaire: reperage et prise en charge initiale en premier recours Internet
[10]   Serum folate levels in bipolar disorder: a systematic review and meta-analysis [J].
Hsieh, Yung-Chi ;
Chou, Li-Shiu ;
Lin, Ching-Hua ;
Wu, Hung-Chi ;
Li, Dian-Jeng ;
Tseng, Ping-Tao .
BMC PSYCHIATRY, 2019, 19 (01)